Effects of Olmesartan Medoxomil, an Angiotensin II Type 1 Receptor Antagonist, on Plasma Concentration of B-Type Natriuretic Peptide, in Hypertensive Patients with Type 2 Diabetes Mellitus: A Preliminary, Observational, Open-Label Study

Author： Kawai Toshihide   Takei Izumi   Shimada Akira  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.31, Iss.4, 2011-04, pp. : 237-245

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antihypertensive Efficacy of the Losartan/Hydrochlorothiazide Combination and its Effect on Plasma B-Type Natriuretic Peptide in Hypertensive Patients Uncontrolled by Angiotensin II Type 1 Receptor Antagonist-Based Therapy: A Multicentre Prospective Observational Study

By Meno Hiroshi  

Clinical Drug Investigation, Vol. 32, Iss. 3, 2012-03 ,pp. : 171-178

Adis International

Access to resources Recommend Favorite

Pioglitazone Lowers Blood Pressure in Hypertensive Patients with Type 2 Diabetes Mellitus: An Open, Multicentre, Observational Study

By Konrad Thomas   Lübben Georg   Franzen Christine  

Clinical Drug Investigation, Vol. 25, Iss. 5, 2005-01 ,pp. : 337-340

Adis International

Access to resources Recommend Favorite

Seated Cuff Blood Pressure-Lowering Efficacy of an Olmesartan Medoxomil-Based Treatment Regimen in Patients with Type 2 Diabetes Mellitus

By Kereiakes Dean J.  

Drugs in R&D, Vol. 11, Iss. 3, 2011-09 ,pp. : 251-257

Adis International

Access to resources Recommend Favorite

ACE Inhibitor and Angiotensin II Type 1 Receptor Antagonist Therapies in Elderly Patients with Diabetes Mellitus: Are They Underutilized?

By >   Winkelmayer Wolfgang C.  

Drugs & Aging, Vol. 27, Iss. 2, 2010-02 ,pp. : 87-94

Adis International

Access to resources Recommend Favorite

An Olmesartan Medoxomil-Based Treatment Algorithm is Effective in Achieving 24-Hour BP Control in Patients with Type 2 Diabetes Mellitus, Regardless of Age, Race, Sex, or Severity of Hypertension: Subgroup Analysis of the BENIFICIARY Study

By Neutel Joel M.  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 5, 2010-10 ,pp. : 289-303

Adis International

Access to resources Recommend Favorite